Skip to main content
. Author manuscript; available in PMC: 2017 Aug 21.
Published in final edited form as: Am J Surg Pathol. 2016 May;40(5):636–644. doi: 10.1097/PAS.0000000000000578

Figure 2.

Figure 2

Gastric-type adenocarcinomas exhibiting diffuse positivity with CK7 (a), focal positivity with CK20 (b), diffuse positivity with CEA (c), diffuse positivity with CDX2 (d), diffuse positivity with CA19.9 (e) and focal positivity with CA125 (f).